Publication | Closed Access

Colesevelam Hydrochloride-Ezetimibe Combination Lipid-Lowering Therapy in Patients with Diabetes or Metabolic Syndrome and a History of Statin Intolerance

ObesityMetabolic SyndromeLipid DisorderStatin IntoleranceCardiovascular DiseaseDiabetesPharmacologyHyperlipidemiaPharmacotherapyLipoprotein MetabolismMedicineAtherosclerosisDyslipidemia